Profile
Racheli Ofir is currently the Co-Chief Executive and Chief Technology Officer at Betalin Therapeutics Ltd. Prior to this, she worked at Pluri, Inc. as the Vice President of Data and Intellectual Property from 2007 to 2022.
She holds a doctorate degree from both Technion-Israel Institute of Technology and Israel Institute of Technology.
Racheli Ofir active positions
| Companies | Position | Start |
|---|---|---|
Betalin Therapeutics Ltd.
Betalin Therapeutics Ltd. Packaged SoftwareTechnology Services Develops micro-pancreas and cell technology | Chief Executive Officer | 2022-11-30 |
Former positions of Racheli Ofir
| Companies | Position | End |
|---|---|---|
| PLURI INC. | Chief Tech/Sci/R&D Officer | 2022-04-30 |
Training of Racheli Ofir
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Pluri, Inc.
Pluri, Inc. BiotechnologyHealth Technology Develops placenta-based cell therapy products for the treatment of muscle trauma and hematological disorders, radiation damage and inflammation | Health Technology |
Technion-Israel Institute of Technology
Technion-Israel Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Israel Institute of Technology
Israel Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Betalin Therapeutics Ltd.
Betalin Therapeutics Ltd. Packaged SoftwareTechnology Services Develops micro-pancreas and cell technology | Technology Services |
- Stock Market
- Insiders
- Racheli Ofir
















